Increased cardiac index due to terbutaline treatment aggravates capillary-alveolar macromolecular leakage in oleic acid lung injury in dogs

Critical Care

Volumn 13, Issue 5, 2009, Pages

  Briot, Raphael ^a   Bayat, Sam ^a   Anglade, Daniel ^a   Martiel, Jean Louis ^a   Grimbert, Francis ^a  

^a LABORATOIRE TIMC IMAG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; FLUORESCEIN; OLEIC ACID; TERBUTALINE; BRONCHODILATING AGENT;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; BRONCHOSCOPE; CAPILLARY LEAK SYNDROME; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG INFUSION; HEART INDEX; HEART OUTPUT; IN VIVO STUDY; LUNG ALVEOLUS; LUNG INJURY; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRACHEOBRONCHIAL TOILET; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DOG; LUNG LAVAGE; METHODOLOGY; MONITORING; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE; BRONCHODILATOR AGENTS; CAPILLARY LEAK SYNDROME; CARDIAC OUTPUT; DEXTRANS; DOGS; LUNG INJURY; MONITORING, PHYSIOLOGIC; OLEIC ACID; PULMONARY ALVEOLI; TERBUTALINE;

EID: 77949881927     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8137     Document Type: Article

References (44)

1. Fuchs-Buder T, de Moerloose P, Ricou B, Reber G, Vifian C, Nicod L, Romand JA, Suter PM. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med 1996, 153:163-167.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349. 10.1056/NEJM200005043421806, 10793167.
3. Idell S. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 2003, 31:S213-220. 10.1097/01.CCM.0000057846.21303.AB, 12682443.
4. Clark JG, Milberg JA, Steinberg KP, Hudson LD. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995, 122:17-23.
5. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314. 10.1378/chest.108.5.1303, 7587434.
6. Briot R, Bayat S, Anglade D, Martiel JL, Grimbert F. Monitoring the capillary-alveolar leakage in an A.R.D.S. model using broncho-alveolar lavage. Microcirculation 2008, 15:237-249. 10.1080/10739680701647410, 18386219.
7. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM, Zee JS, Bresser P, Poll T. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005, 172:878-884. 10.1164/rccm.200503-451OC, 15994467.
8. Perkins GD, McAuley DF, Richter A, Thickett DR, Gao F. Bench-to-bedside review: beta2-agonists and the acute respiratory distress syndrome. Crit Care 2004, 8:25-32. 420065, 14975042, 10.1186/cc2417.
9. McAuley DF, Frank JA, Fang X, Matthay MA. Clinically relevant concentrations of beta2-adrenergic agonists stimulate maximal cyclic adenosine monophosphate-dependent airspace fluid clearance and decrease pulmonary edema in experimental acid-induced lung injury. Crit Care Med 2004, 32:1470-1476. 10.1097/01.CCM.0000129489.34416.0E, 15241090.
10. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002, 82:569-600.
11. Perkins GD, McAuley DF, Thickett DR, Gao F. The beta-Agonist Lung Injury Trial (BALTI): A Randomized Placebo-controlled Clinical Trial. Am J Respir Crit Care Med 2006, 173:281-287. 10.1164/rccm.200508-1302OC, 16254268.
12. Matthay M, Brower R, Thompson B, Schoenfeld D, Eisner M, Carson S, Moss M, Douglas I, Hite D, MacIntyre N, Liu KD. Randomized, Placebo-Controlled Trial of an Aerosolized Beta-2 Adrenergic Agonist (Albuterol) for the Treatment of Acute Lung Injury. Am J Respir Crit Care Med 2009, 179:A2166.
13. Groeneveld AB, den Hollander W, Straub J, Nauta JJ, Thijs LG. Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock. Circ Shock 1990, 30:185-205.
14. Wetterberg T, Svensjo E, Larsson A, Sigurdsson G, Z GW, Willen H. Acute lung injury monitored with radiolabeled transferrin and lung volume measurements. Acta Anaesthesiol Scand 1989, 33:359-368. 10.1111/j.1399-6576.1989.tb02924.x, 2800972.
15. Schreiber T, Hueter L, Gaser E, Schmidt B, Schwarzkopf K, Karzai W. Effects of a catecholamine-induced increase in cardiac output on lung injury after experimental unilateral pulmonary acid instillation. Crit Care Med 2007, 35:1741-1748. 10.1097/01.CCM.0000269374.85160.BF, 17522573.
16. Hakim TS, Maarek JM, Chang HK. Estimation of pulmonary capillary pressure in intact dog lungs using the arterial occlusion technique. Am Rev Respir Dis 1989, 140:217-224.
17. Bayat S, Anglade D, Menaouar A, Martiel JL, Lafond JL, Benchetrit G, Grimbert FA. In vivo measurement of lung capillary-alveolar macromolecule permeability by saturation bronchoalveolar lavage. Crit Care Med 2000, 28:2937-2942. 10.1097/00003246-200008000-00042, 10966275.
18. Berthiaume Y, Matthay MA. Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol 2007, 159:350-359. 2682357, 17604701, 10.1016/j.resp.2007.05.010.
19. Reed RK, Townsley MI, Korthuis RJ, Taylor AE. Analysis of lymphatic protein flux data. V. Unique PS products and sigma dS at low lymph flows. Am J Physiol 1991, 261:H728-740.
20. Ishibashi M, Reed RK, Townsley MI, Parker JC, Taylor AE. Albumin transport across pulmonary capillary-interstitial barrier in anesthetized dogs. J Appl Physiol 1991, 70:2104-2110. 10.1063/1.349446, 1864792.
21. Grimbert FA, Parker JC, Taylor AE. Increased pulmonary vascular permeability following acid aspiration. J Appl Physiol 1981, 51:335-345.
22. Grimbert FA, Martin D, Parker JC, Taylor AE. Lymph flow during increases in pulmonary blood flow and microvascular pressure in dogs. Am J Physiol 1988, 255:H1149-1155.
23. Hasinoff I, Ducas J, Prewitt RM. Increased cardiac output increases lung water in canine permeability pulmonary edema. J Crit Care 1988, 3:225-231. 10.1016/0883-9441(88)90106-2.
24. Schuster DP. ARDS: clinical lessons from the oleic acid model of acute lung injury. Am J Respir Crit Care Med 1994, 149:245-260.
25. Leeman M, Lejeune P, Closset J, Vachiery JL, Melot C, Naeije R. Nature of pulmonary hypertension in canine oleic acid pulmonary edema. J Appl Physiol 1990, 69:293-298.
26. Brimioulle S, Julien V, Gust R, Kozlowski JK, Naeije R, Schuster DP. Importance of hypoxic vasoconstriction in maintaining oxygenation during acute lung injury. Crit Care Med 2002, 30:874-880. 10.1097/00003246-200204000-00027, 11940762.
27. Bishop MJ, Cheney FW. Vasodilators worsen gas exchange in dog oleic-acid lung injury. Anesthesiology 1986, 64:435-439. 10.1097/00000542-198604000-00004, 3963452.
28. Pellett AA, Lord KC, Champagne MS, deBoisblanc BP, Johnson RW, Levitzky MG. Pulmonary capillary pressure during acute lung injury in dogs. Crit Care Med 2002, 30:403-409. 10.1097/00003246-200202000-00023, 11889320.
29. Dauber IM, Weil JV. Lung injury edema in dogs. Influence of sympathetic ablation. J Clin Invest 1983, 72:1977-1986. 437038, 6315774, 10.1172/JCI111162.
30. Schuster DP, Stephenson AH, Holmberg S, Sandiford P. Effect of eicosanoid inhibition on the development of pulmonary edema after acute lung injury. J Appl Physiol 1996, 80:915-923.
31. Velazquez M, Schuster DP. Pulmonary blood flow distribution after lobar oleic acid injury: a PET study. J Appl Physiol 1988, 65:2228-2235.
32. Anglade D, Corboz M, Menaouar A, Parker JC, Sanou S, Bayat S, Benchetrit G, Grimbert FA. Blood flow vs. venous pressure effects on filtration coefficient in oleic acid-injured lung. J Appl Physiol 1998, 84:1011-1023.
33. Schuster DP, Haller JW, Velazquez M. A positron emission tomographic comparison of diffuse and lobar oleic acid lung injury. J Appl Physiol 1988, 64:2357-2365.
34. Lachmann B, Robertson B, Vogel J. In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand 1980, 24:231-236. 10.1111/j.1399-6576.1980.tb01541.x, 7445941.
35. Cohen AB, Batra GK. Bronchoscopy and lung lavage induced bilateral pulmonary neutrophil influx and blood leukocytosis in dogs and monkeys. Am Rev Respir Dis 1980, 122:239-247.
36. Von Essen SG, Robbins RA, Spurzem JR, Thompson AB, McGranaghan SS, Rennard SI. Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis 1991, 144:848-854.
37. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989, 84:1609-1619. 304027, 2553777, 10.1172/JCI114338.
38. Youssef HA, Sigurdsson GH, Christenson JT, Owunwanne A. Use of indium-111-labeled transferrin to study plasma extravasation during endotoxin shock and the effects of the beta-2 agonist terbutaline. Am J Physiol Imaging 1991, 6:85-89.
39. Knox J, Youn YK, Lalonde C, Demling R. Effect of dobutamine on oxygen consumption and fluid and protein losses after endotoxemia. Crit Care Med 1991, 19:525-531. 10.1097/00003246-199104000-00012, 2019139.
40. Gnidec AG, Finley RR, Sibbald WJ. Effect of dobutamine on lung microvascular fluid flux in sheep with "sepsis syndrome". Chest 1988, 93:180-186. 10.1378/chest.93.1.180, 3335150.
41. Licker M, Tschopp JM, Robert J, Frey JG, Diaper J, Ellenberger C. Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. Chest 2008, 133:845-852. 10.1378/chest.07-1710, 17989152.
42. Atabai K, Ware LB, Snider ME, Koch P, Daniel B, Nuckton TJ, Matthay MA. Aerosolized beta(2)-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 2002, 28:705-711. 10.1007/s00134-002-1282-x, 12107675.
43. Hastings RH, Folkesson HG, Matthay MA. Mechanisms of alveolar protein clearance in the intact lung. Am J Physiol Lung Cell Mol Physiol 2004, 286:L679-689. 10.1152/ajplung.00205.2003, 15003932.
44. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575. 10.1056/NEJMoa062200, 16714767.